Physician profile
Mark Shasti
NPI 1295078848
$59,171.91
in general payments reported to CMS, 2019-2025
14 companies · $653 in 2025
The $653 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,885 · 2020: $218 · 2021: $4,324 · 2022: $35K · 2023: $10K · 2024: $6,652 · 2025: $653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $4,302 · Food and Beverage: $1,484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,650.00 |
| Travel and Lodging | $4,301.76 |
| Food and Beverage | $1,484.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $50,728.84 | 2021-2025 | Mazor X System, Stealthstation S8 Platform, Unid_pass |
| Stryker Corporation | $5,848.35 | 2019-2024 | N/A, Everest Spinal System |
| Medtronic USA, INC. | $700.28 | 2019-2020 | |
| Medacta USA, INC. | $602.21 | 2024 | |
| Si-Bone, INC. | $331.19 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $216.75 | 2019 | |
| Innovasis INC | $204.53 | 2023 | |
| Acuity Surgical Devices, LLC | $129.88 | 2019 | |
| Augmedics INC. | $120.87 | 2021 | |
| Nuvasive, INC. | $112.87 | 2019 | |
| Ethicon US, LLC | $103.56 | 2019 | |
| Depuy Synthes Sales INC. | $29.13 | 2020 | |
| Aesculap Implant Systems, LLC | $22.62 | 2021 | |
| Orthofix Medical, INC. | $20.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Shasti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.